Better-than-expected price data can’t quite blunt worries about consumers pulling back, as companies keep scrambling to ...

Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating ...

According to "Thunderbolts*" director Jake Schreier, he intends to make it a "symbol of things taking a darker turn." Read ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through ...

After hours: March 12 at 7:59:57 PM EDT Loading Chart for NVO ...

2-Year U.S. Treasury Note Continuous Contract $103.438-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.602-0.125-0.12% 10-Year U.S. Treasury Note Continuous Contract $110.422-0.219 ...